BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 18684832)

  • 21. Development of an oncolytic HSV vector fully retargeted specifically to cellular EpCAM for virus entry and cell-to-cell spread.
    Shibata T; Uchida H; Shiroyama T; Okubo Y; Suzuki T; Ikeda H; Yamaguchi M; Miyagawa Y; Fukuhara T; Cohen JB; Glorioso JC; Watabe T; Hamada H; Tahara H
    Gene Ther; 2016 Jun; 23(6):479-88. PubMed ID: 26905369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The domains of glycoprotein D required to block apoptosis induced by herpes simplex virus 1 are largely distinct from those involved in cell-cell fusion and binding to nectin1.
    Zhou G; Avitabile E; Campadelli-Fiume G; Roizman B
    J Virol; 2003 Mar; 77(6):3759-67. PubMed ID: 12610150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A herpes simplex virus 2 glycoprotein D mutant generated by bacterial artificial chromosome mutagenesis is severely impaired for infecting neuronal cells and infects only Vero cells expressing exogenous HVEM.
    Wang K; Kappel JD; Canders C; Davila WF; Sayre D; Chavez M; Pesnicak L; Cohen JI
    J Virol; 2012 Dec; 86(23):12891-902. PubMed ID: 22993162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutations in herpes simplex virus glycoprotein D that prevent cell entry via nectins and alter cell tropism.
    Manoj S; Jogger CR; Myscofski D; Yoon M; Spear PG
    Proc Natl Acad Sci U S A; 2004 Aug; 101(34):12414-21. PubMed ID: 15273289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1.
    Wang K; Tomaras GD; Jegaskanda S; Moody MA; Liao HX; Goodman KN; Berman PW; Rerks-Ngarm S; Pitisuttithum P; Nitayapan S; Kaewkungwal J; Haynes BF; Cohen JI
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28701403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An HSV-1 gD mutant virus as an entry-impaired live virus vaccine.
    Awasthi S; Lubinski JM; Eisenberg RJ; Cohen GH; Friedman HM
    Vaccine; 2008 Feb; 26(9):1195-203. PubMed ID: 18243431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of linker-insertion mutations in herpes simplex virus 1 gD on glycoprotein-induced fusion with cells expressing HVEM or nectin-1.
    Jogger CR; Montgomery RI; Spear PG
    Virology; 2004 Jan; 318(1):318-26. PubMed ID: 14972557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell-to-cell spread of wild-type herpes simplex virus type 1, but not of syncytial strains, is mediated by the immunoglobulin-like receptors that mediate virion entry, nectin1 (PRR1/HveC/HIgR) and nectin2 (PRR2/HveB).
    Cocchi F; Menotti L; Dubreuil P; Lopez M; Campadelli-Fiume G
    J Virol; 2000 Apr; 74(8):3909-17. PubMed ID: 10729168
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Replication-competent herpes simplex virus retargeted to HER2 as therapy for high-grade glioma.
    Gambini E; Reisoli E; Appolloni I; Gatta V; Campadelli-Fiume G; Menotti L; Malatesta P
    Mol Ther; 2012 May; 20(5):994-1001. PubMed ID: 22354378
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retargeting Strategies for Oncolytic Herpes Simplex Viruses.
    Campadelli-Fiume G; Petrovic B; Leoni V; Gianni T; Avitabile E; Casiraghi C; Gatta V
    Viruses; 2016 Feb; 8(3):63. PubMed ID: 26927159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monoclonal antibodies to distinct sites on herpes simplex virus (HSV) glycoprotein D block HSV binding to HVEM.
    Nicola AV; Ponce de Leon M; Xu R; Hou W; Whitbeck JC; Krummenacher C; Montgomery RI; Spear PG; Eisenberg RJ; Cohen GH
    J Virol; 1998 May; 72(5):3595-601. PubMed ID: 9557640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of HVEM receptor in activation of nuclear factor kappaB by herpes simplex virus 1 glycoprotein D.
    Sciortino MT; Medici MA; Marino-Merlo F; Zaccaria D; Giuffrè-Cuculletto M; Venuti A; Grelli S; Mastino A
    Cell Microbiol; 2008 Nov; 10(11):2297-311. PubMed ID: 18671825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative usage of herpesvirus entry mediator A and nectin-1 by laboratory strains and clinical isolates of herpes simplex virus.
    Krummenacher C; Baribaud F; Ponce de Leon M; Baribaud I; Whitbeck JC; Xu R; Cohen GH; Eisenberg RJ
    Virology; 2004 May; 322(2):286-99. PubMed ID: 15110526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Herpes simplex virus 1 recombinant virions exhibiting the amino terminal fragment of urokinase-type plasminogen activator can enter cells via the cognate receptor.
    Kamiyama H; Zhou G; Roizman B
    Gene Ther; 2006 Apr; 13(7):621-9. PubMed ID: 16292350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Downregulation of endogenous nectin1 in human keratinocytes by herpes simplex virus 1 glycoprotein D excludes superinfection but does not affect NK cell function.
    Kite J; Hill M; Preston N; Rubina A; Kollnberger S; Wang ECY; Elliott G
    J Gen Virol; 2024 Mar; 105(3):. PubMed ID: 38471041
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rethinking herpes simplex virus: the way to oncolytic agents.
    Campadelli-Fiume G; De Giovanni C; Gatta V; Nanni P; Lollini PL; Menotti L
    Rev Med Virol; 2011 Jul; 21(4):213-26. PubMed ID: 21626603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Entry of herpes simplex virus mediated by chimeric forms of nectin1 retargeted to endosomes or to lipid rafts occurs through acidic endosomes.
    Gianni T; Campadelli-Fiume G; Menotti L
    J Virol; 2004 Nov; 78(22):12268-76. PubMed ID: 15507614
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the antiviral potential among soluble forms of herpes simplex virus type-2 glycoprotein D receptors, herpes virus entry mediator A, nectin-1 and nectin-2, in transgenic mice.
    Fujimoto Y; Tomioka Y; Ozaki K; Takeda K; Suyama H; Yamamoto S; Takakuwa H; Morimatsu M; Uede T; Ono E
    J Gen Virol; 2017 Jul; 98(7):1815-1822. PubMed ID: 28671524
    [TBL] [Abstract][Full Text] [Related]  

  • 39. αVβ3-integrin relocalizes nectin1 and routes herpes simplex virus to lipid rafts.
    Gianni T; Campadelli-Fiume G
    J Virol; 2012 Mar; 86(5):2850-5. PubMed ID: 22171266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glycoprotein D homologs in herpes simplex virus type 1, pseudorabies virus, and bovine herpes virus type 1 bind directly to human HveC(nectin-1) with different affinities.
    Connolly SA; Whitbeck JJ; Rux AH; Krummenacher C; van Drunen Littel-van den Hurk S; Cohen GH; Eisenberg RJ
    Virology; 2001 Feb; 280(1):7-18. PubMed ID: 11162814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.